PATENTED INGREDIENT
UC-II® Patented Undenatured Type II Collagen (40 mg/day, Joint Health)
UC-II® Patented Undenatured Type II Collagen (40 mg/day, Joint Health) is a patented ingredient in the ACC Biotech catalogue, developed by Lonza Consumer Health & Nutrition — Lonza Greenwood LLC (formerly InterHealth Nutraceuticals), with United States listed as its origin. This page brings together the ingredient information currently available from ACC Biotech and the enquiry route.

INGREDIENT PROFILE
What this ingredient is documented for
- Origin
- United States
- Developer
- Lonza Consumer Health & Nutrition — Lonza Greenwood LLC (formerly InterHealth Nutraceuticals)
- Undenatured (native) type II collagen derived from chicken sternum cartilage using a patented low-temperature process that preserves the intact triple-helix structure and its bioactive epitopes; brand owned by Lonza (formerly InterHealth Nutraceuticals) and produced in the USA under NSF GMP registration and cGMP (21 CFR 111/117), with a halal grade available
- Mechanism of action — oral tolerance: the preserved epitopes bind to Peyer’s patches in the gut-associated lymphoid tissue and activate regulatory T cells that migrate to joint tissue, moderating the inflammatory response and supporting cartilage repair; a single small 40 mg daily dose (providing approx. 10 mg of native type II collagen) is enough
- Knee osteoarthritis RCT (Lugo et al., Nutrition Journal 2016): 191 randomised subjects over 180 days; UC-II 40 mg/day reduced the total WOMAC score significantly more than placebo (−551 vs −414, p=0.002) and more than glucosamine 1,500 mg + chondroitin 1,200 mg (−551 vs −454, p=0.04), with VAS pain and the Lequesne functional index also superior to both comparators
- Healthy-subject RCT (Lugo et al., JISSN 2013): 55 healthy volunteers with exercise-induced knee discomfort over 120 days; average knee extension improved from 73.2° to 81.0° (p=0.002 vs baseline; p=0.011 vs placebo) and stepmill exercise time before joint discomfort was extended from 1.4 to 2.8 minutes (p=0.019)
- Patent-protected (e.g. US 9,066,926 B2 “Method of reducing exercise-induced joint pain in non-arthritic mammals” and US 8,748,499 B2 “Collagen dispersion and method of producing same”, assignee Lonza Greenwood LLC); no product-related adverse events or clinically significant changes in haematology, blood biochemistry or vital signs were reported across the trials. Applications: joint and mobility supplements, sports nutrition, healthy-ageing formulas
QUICK REFERENCE
Key ingredient facts
- Origin
- United States
- Developer
- Lonza Consumer Health & Nutrition — Lonza Greenwood LLC (formerly InterHealth Nutraceuticals)
About UC-II® Patented Undenatured Type II Collagen (40 mg/day, Joint Health)
UC-II® Patented Undenatured Type II Collagen (40 mg/day, Joint Health) is a patented ingredient in the ACC Biotech catalogue, developed by Lonza Consumer Health & Nutrition — Lonza Greenwood LLC (formerly InterHealth Nutraceuticals), with United States listed as its origin. This page brings together the ingredient information currently available from ACC Biotech and the enquiry route.
Frequently asked questions
These answers summarize ACC Biotech's current catalogue information and enquiry process.
What information is available for UC-II® Patented Undenatured Type II Collagen (40 mg/day, Joint Health)?
This page summarizes the ingredient highlights, origin and developer information currently held in the ACC Biotech catalogue.
How can I request formulation, documentation or sourcing details?
Contact ACC Biotech with the intended dosage form, market and document requirements so the team can follow up with the relevant information.
FORMULATION
Discuss this ingredient with ACC
Bring this ingredient into a formula, documentation and sourcing conversation with the ACC team.



